Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Wiener Klinische Wochenschrift|June 15, 2021
COVID-19-associated myoclonus in a series of five critically ill patientsAlexander Grieb, Tamara Seitz, Reinhard Kitzberger, et al.Hepatology (Baltimore, Md.)|May 6, 2008
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3Peter Ferenci, Harald Brunner, Hermann Laferl, et al.Wiener Klinische Wochenschrift|August 11, 2020
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohortMario Karolyi, Erich Pawelka, Theresa Mader, et al.Gastroenterology|November 14, 2009
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic responsePeter Ferenci, Hermann Laferl, Thomas-Matthias Scherzer, et al.Infection|May 13, 2021
COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, AustriaErich Pawelka, Mario Karolyi, Theresa Mader, et al.European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.Infection|September 9, 2022
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohortMario Karolyi, Andreas Gruebl, Sara Omid, et al.Journal of Hepatology|July 16, 2013
A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infectionSandra Beinhardt, Berit Anna Payer, Christian Datz, et al.Frontiers in Immunology|February 11, 2020
CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic InfectionMaximilian Koblischke, Felicia S Spitzer, David M Florian, et al.Wiener Klinische Wochenschrift|October 27, 2022
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysisMario Karolyi, Lukas Kaltenegger, Erich Pawelka, et al.Pageof 5